SUMMARY Results presented in this paper confirm earlier experiments which showed that microsomal extract of small bowel, preincubated with tumour cells, resulted in complete inhibition of tumour growth. However, experiments in vitro have shown that this effect is due to direct cytotoxicity of the extract and that (a) it is not specific for the small bowel; (b) it is not specific for tumour cells; and (c) the activity is predominantly in the mitochondrial fraction.
In 1951 Bennett, Connon, and Schoenberg reported that preincubation of tumour cells with an extract of small bowel composed of microsomes could prevent the growth of the Gardner lymphoma in mice. This effect, they stated, was specific for small bowel. The purpose of this paper was to repeat their experiments and, if confirmed, extend these findings and to examine the specificity of an extract of small bowel in inhibiting tumour growth.
Methods

PREPARATION OF EXTRACTS
For each experiment three CBA mice were killed and the small bowel, large bowel, stomach and liver were removed. The liver was rinsed with cold isotonic saline and the intestinal organs were opened and flushed clear of all intestinal content. The organs were then weighed and homogenized separately, after adding 4 ml cold isotonic saline per gram, using a Teflon-glass homogenizer for one minute. After filtering through a double layer of gauze, the suspensions were centrifuged at 4000 g for 20 minutes. The 
TUMOUR CELLS
The Gardner lymphoma (Gardner, Dougherty, and Williams, 1944) was maintained by serial intraperitoneal passage in CBA mice. For all tumour experiments 5 x 106 cells/ml were inoculated intraperitoneally. In-vitro experiments were performed using cell suspensions of tumour cells after washing the cells with TC199. The TLX5 lymphoma (Connors and Jones, 1970) was also maintained and used as above.
Experiments and Results
THE EFFECT OF MICROSOMAL PREPARATION ON TUMOUR CELL GROWTH (FRACTION II)
To 1 ml of tumour cells (5 x 106 cells/ml), 1 ml of the microsomal fraction of either small bowel, liver, or a saline control was added and incubated at 37°C for two hours. From this mixture 0'1 ml was injected intraperitoneally into three groups of 10 CBA mice and the subsequent progress noted. The experiments were performed with both tumour systems.
The results are shown in tables I and II and confirm that preincubation of either the intestine, and large intestine were incubated with Gardner lymphoma cells and the viability was assessed as before.
The results are shown in fig 3 and indicate that the activity is present in all three areas of the intestine. In the microsomal fraction there is some difference in activity, the small bowel fraction being the most active.
Discussion
The initial aim of this paper was to confirm the results reported in 1951 by Bennett et al and the first experiment performed in this publication is in agreement with the earlier study. However, in the subsequent studies in vitro it is clear that this activity is not specific to small bowel. In addition it is evident that the activity is not maximal in the microsomal fraction but is greatest in the mitochondrial and brush border pellet. Perhaps the most important feature is that the normal cells are killed more rapidly than tumour cells making the use of the extract less important in therapeutic terms.
The significance of the earlier results was related to the fact that tumours of the small bowel are rarer than tumours of other areas of the gastrointestinal tract and the suggestion was made that there may be something within the small bowel preventing tumour growth. Lowenfels (1973) has recently reviewed this subject and suggests that the rarity of small bowel tumours may be related to (1) the rapid transit of potentially carcinogenic substances in the small bowel; (2) the relative fluidity of the small bowel contents; (3) the relative sterility of the small bowel when compared with the large bowel. More recently Calman (1974) has suggested, and presented evidence in a small animal model to support the hypothesis, that the immunological status of the small bowel may be important.
It remains to establish the exact nature of the active component in gastrointestinal subcellular fractions. Certainly it contains a biological active substance(s) which will kill 100% of cells within 30 minutes. It is likely, however, that the activity is related to the enzymatic activity of gastrointestinal epithelium.
inhibition of tumour growth. 
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